Oncology Institute, Inc.·4

Mar 30, 9:38 AM ET

Chernett Jorey 4

4 · Oncology Institute, Inc. · Filed Mar 30, 2026

Research Summary

AI-generated summary of this filing

Updated

Oncology Institute (TOI) 10% Owner Chernett Jorey Buys 27,429 Shares

What Happened
Chernett Jorey, identified as a 10% owner of Oncology Institute, Inc. (TOI), acquired 27,429 shares on 2026-03-27 via an open market or private purchase (transaction code P). The shares were purchased at $2.96 each for a total reported value of approximately $81,190. This was a purchase (a net acquisition), which investors often view as a more informative signal than sales.

Key Details

  • Transaction date: 2026-03-27
  • Shares acquired: 27,429
  • Price per share: $2.96
  • Total value: ~$81,190
  • Transaction code: P (purchase — open market or private purchase)
  • Filing date: 2026-03-30 (Form 4 accession 0000921895-26-000823) — no late-filing indicator provided in the summary supplied
  • Shares owned after transaction: not reported in the details provided here
  • No footnotes (e.g., 10b5-1 plan, tax withholding) were supplied in the summary

Context
As a reported 10% owner, Jorey is a significant shareholder whose trades must be disclosed under Section 16 rules; 10% owners are large stakeholders but not necessarily company executives. Purchases can be seen as a modestly bullish signal, but they don't prove intent or future performance.

Insider Transaction Report

Form 4
Period: 2026-03-27
Transactions
  • Purchase

    Common Stock

    2026-03-27$2.96/sh+27,429$81,19010,479,358 total
Signature
/s/ Jorey Chernett|2026-03-30

Documents

1 file
  • 4
    form414528003toi_03302026.xmlPrimary

    OWNERSHIP DOCUMENT